# Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency

> **NCT04922398** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ahmed Saad** · enrollment: 60 (estimated)

## Conditions studied

- Premature Ovarian Failure

## Interventions

- **BIOLOGICAL:** platelet rich plasma
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04922398
- **Lead sponsor:** Ahmed Saad
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-20
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04922398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04922398, "Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04922398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*